LONE ENGLEDOWL: Open Payments
NPI 1205235082 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,485 in 94 payments from 15 companies in 2025. Trend: 2023 $1,465 · 2024 $1,854 · 2025 $2,485
Food & beverage: $2,485
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $427 |
| Neurocrine BioSciences, Inc. | 10 | $330 |
| Otsuka America Pharmaceutical, Inc. | 7 | $328 |
| Lundbeck LLC | 16 | $319 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $222 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $160 |
| ACADIA Pharmaceuticals Inc | 4 | $154 |
| Collegium Pharmaceutical, Inc. | 2 | $148 |
| Vanda Pharmaceuticals Inc. | 4 | $147 |
| Axsome Therapeutics, Inc. | 3 | $73 |
Products named: REXULTI, INGREZZA, AUSTEDO XR, CAPLYTA, TRINTELLIX, NUPLAZID, Jornay PM, FANAPT.
Industry payments across TX — which companies pay providers there.
